Tuesday, July 22, 2014
Search Minimize
Search

Enter Search Terms

Print  
Programs Minimize
Print  
Studies Minimize

 

Location: New Programs :101745

ProgramHematology
Diagnosis Region
Trial TypeOther (OTH)
TitleRetrospective Characterization of Certain Blood Test Abnormalities Potentially Aiding the Diagnosis of Mast Cell Activation Disease (MCAD), Especially Mast Cell Activation Syndrome (MCAS)
SponsorMUSC
AuthorshipPI
Sponsor's NumberTMS-2011-A
PhaseN/A
Primary InvestigatorLawrence Afrin afrinl@musc.edu
Study CoordinatorShanta Salzer 843-792-1463 salzers@musc.edu
Trial Number101745
EligibilityInclusion:
1. Eligible patients will be living and deceased patients who are, or had been, diagnosed with any form of MCAD, dating from the first diagnosis of MCAS at MUSC in 2008 to the present.

Exclusion:
Patients who do not meet Inclusion Criteria #1
Hypothesis To characterize prevalence, persistence, frequency, magnitude, magnitude trend, and clinical correlations of abnormalities in certain commonly clinically obtained blood tests in a sizable (250+) single-center population of MCAD patients (predominantly MCAS).
Available Documents Protocol

Print  
Copyright 2009 Terms Of UsePrivacy Statement